All In Biotech

Drug Trial Radar · NCT06310590

Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma

Study on the Safety and Effectiveness of NRT6003 Injection in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Last checked: Nov 19, 2026Latest source record: Feb 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Aug 8, 2023

Primary completion

Jun 10, 2025

Study completion Jun 10, 2025

Sponsor

Sponsor type
Industry
First posted
Mar 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the safety and efficacy of NRT6003 Injection in patients with unresectable HCC.

Conditions

  • Unresectable Hepatocellular Carcinoma

Interventions

  • NRT6003 InjectionDrug

    Selective internal radiation therapy (SIRT) with TareSphere

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events/ Severe adverse eventsTime frame: Up to 12 months
  2. Localized Objective response rates (ORR)Time frame: Up to 6 months (initial tumor assessment after administration)

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Zhongshan Hospital, Fudan University

    Shanghai, China

  • Anhui Provincial Hospital

    Hefei, Anhui, China

  • The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • Hunan Provincial People's Hospital

    Changsha, Hunan, China

  • Zhongda Hospital, Southeast University

    Nanjing, Jiangsu, China

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China

  • The Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuan, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.